The Fertility Show, Manchester Central, 24-25 March 2018
Page URL:

Failed stem cell transplant leaves woman with nose tissue on spine

14 July 2014
Appeared in BioNews 762

A paraplegic woman in the USA has developed a growth of nasal tissue in her back eight years after failed stem cell therapy.

Surgeons at the University of Iowa Hospitals and Clinics removed the benign three-centimetre-long growth that was causing the anonymous 28-year-old woman pain, and published the results in the Journal of Neurosurgery: Spine. The removed growth consisted mainly of nasal tissue, including bits of bone and nerve branches that had not connected with spinal nerves. Further, it secreted 'a thick copious mucus-like material', according to neurosurgeon Dr Brian Dlouhy, who removed the growth.

Although rare cases of stem cell treatments causing growths have been recorded before, this seems to be the first one carried out at a Western hospital as part of an approved clinical trial.

'It is sobering', Professor George Daley from Harvard Stem Cell Institute told New Scientist. He added: 'It speaks directly to how primitive our state of knowledge is about how cells integrate and divide and expand'.

The early-stage trials were run by a team at the Hospital de Egas Moniz in Lisbon, Portugal to explore the potential of nasal cells in treating paralysis. In this case, the woman had olfactory stem cells implanted in her spine eight years ago, in hope that they would develop into neural cells and help repair the nerve damage in her spine.

Tissue at the top of the nasal passages contains both olfactory stem cells and olfactory ensheathing cells, which support and guide the growth of the neurons. Olfactory ensheathing cells are often used in spinal cord therapy trials, while olfactory stem cells have the ability to take on the characteristics of other cells in the body because they are partially made up of progenitor cells.

Dr Jean Peduzzi-Nelson, a stem cell researcher at Wayne State University in Michigan, advised the team who conducted the surgical technique, which had previously been tested on rodents. She told New Scientist: 'I am saddened to learn of this adverse event, however, the incidence of this problem is less than one percent'. She added that 'many patients receiving this treatment have had remarkable recovery'.

In 2010, the researchers in Lisbon published their results using this method on 20 people paralysed at various locations in their spine. They found that eleven patients experienced some recovery of movement or sensation, one person's paralysis got worse, whilst one developed meningitis, and four others experienced minor adverse events. However, it is unclear whether the woman from the USA was part of this trial.

27 November 2017 - by Ewa Zotow 
Paraplegic rats were able to walk after being treated with human stem cells. This is the first time lower body movement has been restored after an animal's spinal cord has been completely severed...
27 October 2014 - by Dr Shanya Sivakumaran 
A man who was paralysed from the chest down has begun to walk again, with the use of a frame, following the transplantation of cells into his spinal cord...
7 July 2014 - by Dr Daniel Grimes 
In one of the first experiments to grow tissue from adult stem cells, scientists have grown corneas in the lab...
28 May 2014 - by Dr Molly Godfrey 
Stem cells created from a monkey's own skin cells can be transplanted back into the animal without a high risk of tumour formation, researchers have reported...
12 May 2014 - by Dr Greg Ball 
Two major reviews of clinical trials using stem cells to treat advanced heart disease have found a positive effect of the stem cell treatment, but caution against overstating this effect until more trials are carried out...
10 March 2014 - by Dr Greg Ball 
Researchers have developed a technique to grow cartilage structures from the stem cells found in human fat tissue. They hope that this will pave the way for ears and noses to be grown in the laboratory and used in transplants...
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.